Clinical characteristics and risk factors for fatal outcome of patients receiving Sun's procedure after previous cardiac surgery

被引:3
|
作者
Sun, Guang-Long [1 ]
Sun, Li-Zhong [2 ]
Zhu, Jun-Ming [2 ]
Liu, Yong-Min [2 ]
Ge, Yi-Peng [2 ]
Xu, Shi-Jun [2 ]
机构
[1] Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiovasc Surg, Beijing 100029, Peoples R China
[2] Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing Aort Dis Ctr,Dept Cardiovasc Surg, 2 Anzhen Rd, Beijing 100029, Peoples R China
关键词
Sun's procedure; Clinical characteristic; Risk factors; Survival analysis; TETRAFURCATE GRAFT; THORACIC AORTA; REOPERATIONS; MORTALITY; OPERATION; ROOT;
D O I
10.1016/j.asjsur.2020.03.014
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Cardiac reoperation has always been a difficult problem in clinical practice. Because of the difficulty of operation, the incidence of complications and mortality rate is high. Secondary aortic surgery, especially the reoperation involving arch, has higher risk and is more difficult for patients with renal failure. Sun's operation (total arch replacement thorn stent elephant nose) has achieved good results in the treatment of diseases involving aortic arch, and occupies an important position in the treatment of patients with secondary arch lesions after cardiac surgery. Methods: A total of 395 patients with a history of cardiac surgery were recorded in our center from January 1, 2009 to December 31, 2017, among whom 118 (30.1%) patients underwent aortic reoperation via the original incision using Sun's aortic procedure owing to postoperative great vessel disease. We analyzed the clinical data and survival time, and used Cox regression to analyze the risk factors for 30-day mortality as well as long term mortality. Results: The interval between the last operation and the present operation was 0.08-19 years. Sixteen patients died within 30 days after operation and the average mortality rate was 13.6%. During the follow-up period, 28 patients died, with the mortality rate of 23.7%. As of December 31, 2017, the longest survival time was 9.36 years, and the survival time of 70 patients was more than 3.05 years. The main risk factor associated with the 30-day survival was cardiopulmonary bypass (CPB) time. The longer the CPB time was, the greater the risk of death was. The main risk factors associated with the long-term survival were CPB time and 24-h bleeding volume. The longer the CPB time was, the more the 24-h bleeding volume was, the higher long-term mortality rate was. Conclusion: The second Sun's operation, as a surgical treatment after cardiac surgery, showed a high survival rate, with long survival time and good curative effect. CPB is the main risk factor for the 30-day survival state after operation, and CPB time and 24-h bleeding volume are the main risk factors for the long-term survival state after operation. (C) 2020 Asian Surgical Association and Taiwan Robotic Surgery Association. Publishing services by Elsevier B.V.Y
引用
收藏
页码:87 / 92
页数:6
相关论文
共 50 条
  • [31] Association of blood donor?s biological characteristics on outcomes of cardiac surgery patients receiving red blood cells transfusion
    Gupta, Vidushi
    Patidar, Gopal K.
    Hote, Milind
    Mehar, Radheshyam
    Dhiman, Yashaswi
    Hazarika, Anjali
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2023, 30 (01) : 130 - 136
  • [32] Risk factors among stroke subtypes and its impact on the clinical outcome of patients of Northern Portugal under previous aspirin therapy
    Freitas-Silva, Margarida
    Medeiros, Rui
    Nunes, Jose Pedro L.
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2021, 203
  • [33] Early delirium after cardiac surgery: an analysis of incidence and risk factors in elderly (≥65 years) and very elderly (≥80 years) patients
    Kotfis, Katarzyna
    Szylinska, Aleksandra
    Listewnik, Mariusz
    Strzelbicka, Marta
    Brykczynski, Miroslaw
    Rotter, Iwona
    Zukowski, Maciej
    CLINICAL INTERVENTIONS IN AGING, 2018, 13 : 1061 - 1070
  • [34] Analysis of risk factors for venous thromboembolism in patients after thoracic surgery: A clinical study of 167 cases
    Wang Fei
    Zhang Jian
    Gao Zhi
    Wang Rong
    Li Jianxin
    Gu Yongquan
    Wang Weiping
    TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 26 (01): : 93 - 98
  • [35] Clostridioides difficile infection after cardiac surgery: Assessment of prevalence, risk factors and clinical outcomes-retrospective study
    Rzucidlo-Hymczak, Anna
    Hymczak, Hubert
    Olechowska-Jarzab, Aldona
    Gorczyca, Anna
    Kapelak, Boguslaw
    Drwila, Rafal
    Plicner, Dariusz
    PEERJ, 2020, 8
  • [36] Outcome analysis for prediction of early and long-term survival in patients receiving intra-aortic balloon pumping after cardiac surgery
    Kamiya, Hiroyuki
    Schilling, Maximilian
    Akhyari, Payam
    Ruhparwar, Arjang
    Kallenbach, Klaus
    Karck, Matthias
    Lichtenberg, Artur
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2016, 64 (10) : 584 - 591
  • [37] Editor's Choice - Abdominal Compartment Syndrome after Surgery for Abdominal Aortic Aneurysm: Subgroups, Risk Factors, and Outcome
    Ersryd, Samuel
    Gidlund, Khatereh Djavani
    Wanhainen, Anders
    Smith, Linn
    Bjorck, Martin
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2019, 58 (05) : 671 - 679
  • [38] Readmission to the Intensive Care Unit after Fast-Track Cardiac Surgery: An Analysis of Risk Factors and Outcome according to the Type of Operation
    Toraman, Fevzi
    Senay, Sahin
    Gullu, Umit
    Karabulut, Hasan
    Alhan, Cem
    HEART SURGERY FORUM, 2010, 13 (04) : E212 - E217
  • [39] Clinical characteristics and assessment of risk factors in patients with influenza A-induced severe pneumonia after the prevalence of SARS-CoV-2
    Ma, Yujie
    Gao, Qiang
    OPEN MEDICINE, 2024, 19 (01):
  • [40] Clinical characteristics, risk factors and outcome of severe Norovirus infection in kidney transplant patients: a case-control study
    Gras, Julien
    Abdel-Nabey, Moustafa
    Dupont, Axelle
    Le Goff, Jerome
    Molina, Jean-Michel
    Peraldi, Marie Noelle
    BMC INFECTIOUS DISEASES, 2021, 21 (01)